Recombinant Escherichia coli O157:H7 Rhomboid protease GlpG (glpG) is a genetically engineered intramembrane serine protease derived from the pathogenic E. coli O157:H7 strain. This enzyme belongs to the rhomboid protease family (EC 3.4.21.105), which catalyzes proteolytic cleavage of transmembrane substrates within lipid bilayers . GlpG plays critical roles in bacterial membrane protein quality control, substrate recognition, and regulated intramembrane proteolysis (RIP) . Recombinant versions are produced for biochemical and structural studies, enabling insights into bacterial pathogenesis and protease mechanisms .
Cleaves substrates at hydrophilic regions near transmembrane domains (TMDs), targeting sequences like Ser-Asp motifs .
Requires no cofactors; activity is pH-dependent, optimal at neutral conditions .
Preferentially cleaves orphan subunits of bacterial respiratory complexes (e.g., HybA, FdnH) that lack stabilizing partners .
Recognizes structural features of TMDs rather than specific consensus sequences .
5.1 Role in Membrane Quality Control
GlpG selectively degrades orphan subunits of hydrogenase-2 and formate dehydrogenase complexes, preventing accumulation of non-functional proteins .
Disruption of glpG reduces E. coli O157:H7 survival in murine gut models by 100-fold .
Polar effects on glpR (a glycerol metabolism regulator) impair fatty acid β-oxidation, critical for nutrient utilization in mucus .
5.3 Inhibitor Binding
Phosphonofluoridate inhibitors covalently bind the catalytic serine, stabilizing conformational changes in loops L1 and L5 .
KEGG: ecf:ECH74115_4732
Rhomboid proteases, including GlpG, are membrane-integrated enzymes that hydrolyze peptide bonds specifically within transmembrane domains of protein substrates . In Escherichia coli O157:H7, an enterohemorrhagic strain responsible for hemorrhagic colitis and hemolytic uremic syndrome in humans, GlpG may play roles in membrane protein regulation that could influence virulence pathways .
E. coli O157:H7 is a major public health concern globally, with higher hospitalization and fatality rates compared to other enteric pathogens despite lower total case numbers . The study of GlpG in this context provides insights into:
Membrane protein processing mechanisms in pathogenic bacteria
Potential regulatory pathways involved in bacterial adaptation to host environments
Novel targets for therapeutic intervention against this important pathogen
While the specific contributions of GlpG to E. coli O157:H7 pathogenesis remain under investigation, its conservation across bacterial species suggests fundamental biological importance.
Based on documented methodologies, the following expression system has proven effective for recombinant GlpG production:
Vector selection: Expression vector containing an N-terminal His6-tag for purification purposes
Host strain: E. coli BL21(DE3)-RP strain (Agilent Technologies)
Growth conditions: LB media supplemented with 100 mg/l ampicillin at 37°C until OD600nm = 0.6
Induction protocol: Cooling culture on ice for 20 minutes followed by addition of 0.5 mM isopropyl β-thiogalactopyranoside (IPTG)
Post-induction incubation: 15°C for 16 hours to promote proper folding
This approach balances protein yield with proper folding, which is particularly important for membrane proteins like GlpG. The lower temperature during the induction phase helps minimize inclusion body formation and improves the yield of correctly folded, functional protein.
Effective purification of recombinant GlpG involves multiple steps with careful attention to maintaining the integrity of this membrane protein:
Cell lysis: Mechanical disruption methods that efficiently break the cell membrane without denaturing proteins
Membrane fraction isolation: Ultracentrifugation at 50,000 g for 2 hours using an appropriate rotor (e.g., Type 45 Ti rotor, Beckman Coulter)
Solubilization: Treatment with 1% n-dodecyl-β-D-maltopyranoside (DDM) to extract membrane proteins
Affinity chromatography: Purification using Ni2+-NTA affinity chromatography to capture His-tagged GlpG
For higher purity requirements, consider additional chromatography steps such as size exclusion or ion exchange. Good Laboratory Practice (GLP) principles should be followed throughout to ensure accountability and traceability of materials .
Comprehensive quality assessment of purified GlpG should include:
Purity analysis:
SDS-PAGE to verify molecular weight and purity
Western blot with anti-His or anti-GlpG antibodies
Mass spectrometry for precise molecular weight verification
Structural integrity assessment:
Circular dichroism spectroscopy to verify secondary structure content
Thermal shift assays to assess protein stability
Limited proteolysis to evaluate the compactness of protein folding
Functional activity verification:
Proteolytic activity assays using validated model substrates
Binding assays to measure substrate interaction
All verification procedures should be documented following GLP guidelines, including detailed methodology, raw data preservation, and proper reporting of any deviations .
While the search results don't provide specific storage recommendations for GlpG, the following guidelines are based on standard practices for membrane proteins:
Buffer composition: 0.2% DDM, 50 mM TrisHCl, and 200 mM NaCl, pH 8.0
Short-term storage (1-2 weeks): 4°C with protease inhibitors
Medium-term storage (1-3 months): -20°C in single-use aliquots with 10-20% glycerol
Long-term storage (>3 months): -80°C with cryoprotectants
Activity retention should be verified periodically to ensure protein quality. Document all storage conditions and stability testing results according to GLP standards .
Site-directed mutagenesis provides powerful insights into GlpG structure-function relationships. Based on available methodologies:
Mutagenesis methodology:
Strategic mutation targets:
Analysis of mutants:
Comparison of expression levels and folding efficiency
Assessment of structural changes using spectroscopic methods
Quantification of enzymatic parameters (kcat, KM)
Table 1: Example strategies for site-directed mutagenesis of GlpG
| Mutation Type | Target Residues | Purpose | Analysis Method |
|---|---|---|---|
| Cysteine pair introduction | N-terminal (N) region | Conformational studies | Crosslinking, fluorescent labeling |
| Cysteine pair introduction | C-terminal (C) region (G172C/V267C) | Conformational studies | Crosslinking, fluorescent labeling |
| Catalytic triad mutations | Active site residues | Enzymatic mechanism | Activity assays |
| TM domain mutations | Membrane-spanning regions | Substrate recognition | Binding assays, structural studies |
The search results provide specific methodologies for labeling GlpG with fluorescent probes:
Preparation of cysteine variants:
Purify cysteine mutants (e.g., those with N-terminal or C-terminal pairs) to ~50 μM in 0.2% DDM, 50 mM TrisHCl, 200 mM NaCl, pH 8.0
Reduce with 10-fold molar excess of Tris(2-carboxyethyl)phosphine-HCl (TCEP) for 1 hour at room temperature
Labeling reaction:
Applications of labeled GlpG:
Conformational studies using fluorescence spectroscopy
Protein-protein interaction analysis
Real-time monitoring of structural changes during catalysis
These approaches allow researchers to gain insights into the dynamic behavior of GlpG that cannot be achieved through static structural methods alone.
Studying GlpG-substrate interactions requires specialized approaches suitable for membrane-integrated proteases:
In vitro reconstitution systems:
Incorporation of purified GlpG into liposomes or nanodiscs
Addition of potential substrates in detergent-solubilized or membrane-incorporated form
Monitoring cleavage products by gel electrophoresis or mass spectrometry
Binding assays:
Surface plasmon resonance with immobilized GlpG
Microscale thermophoresis for solution-based binding measurements
Isothermal titration calorimetry for thermodynamic parameters
Computational approaches:
Molecular docking to predict substrate binding modes
Molecular dynamics simulations to study dynamic interactions
Bioinformatic analysis of potential substrates based on sequence patterns
These complementary approaches provide a comprehensive understanding of the molecular basis of substrate recognition and cleavage by GlpG.
When faced with contradictory experimental results, researchers should implement a systematic approach to reconciliation:
Methodological standardization:
Document detailed experimental conditions (buffer composition, temperature, detergent concentration)
Establish control experiments that validate assay performance
Verify reagent quality and consistency (including recombinant protein batches)
Troubleshooting strategies:
Conduct side-by-side comparisons using identical protocols
Analyze potential sources of variability (protein preparation, substrate quality)
Implement statistical approaches to quantify experimental reproducibility
Collaborative verification:
Proper documentation of all reconciliation efforts according to GLP guidelines ensures scientific rigor and facilitates resolution of apparent contradictions .
Cutting-edge approaches for investigating GlpG's role in pathogenesis include:
Genetic manipulation strategies:
CRISPR-Cas9 genome editing to create precise GlpG mutations
Controlled expression systems to modulate GlpG levels during infection
Reporter fusions to monitor GlpG expression and localization
Infection models:
Cell culture systems to study host-pathogen interactions
Animal models to assess virulence in vivo
Organoid cultures for more physiologically relevant conditions
-Omics approaches:
Proteomics to identify GlpG substrates during infection
Transcriptomics to determine effects of GlpG on gene expression
Metabolomics to assess downstream metabolic consequences
These approaches enable researchers to connect molecular mechanisms to pathophysiological outcomes, potentially revealing new therapeutic targets for addressing E. coli O157:H7 infections, which remain a significant public health concern with high hospitalization and fatality rates .
Good Laboratory Practice (GLP) principles are crucial for ensuring the quality and reproducibility of GlpG research:
Test item accountability:
Study documentation:
Method validation:
Adherence to these principles enhances data quality and facilitates regulatory acceptance of research findings.
When encountering unexpected results in GlpG research:
Documentation requirements:
Record all observations in detail, including experimental conditions
Document deviations from expected outcomes
Maintain raw data integrity for future analysis
Reporting procedures:
Follow-up investigations:
Design targeted experiments to explore unexpected results
Consider alternative hypotheses that might explain observations
Conduct literature reviews to identify similar phenomena
This systematic approach transforms unexpected findings from potential problems into valuable research opportunities.